Doctor, stop needling me: an update on alternative routes of insulin administration

Since its introduction, insulin therapy for diabetes has long been equated with pain, anxiety, lifestyle inconvenience and potential injection-site irritation and lipodystrophy. Efforts to develop noninvasive methods for insulin delivery have relied on molecular modifications, absorption enhancers a...

Full description

Saved in:
Bibliographic Details
Published inDiabetes Management Vol. 2; no. 5; pp. 395 - 404
Main Authors Roe, Erin D, Woo, Jason S, Raskin, Philip
Format Journal Article Book Review
LanguageEnglish
Published London Future Medicine Ltd 01.09.2012
Subjects
Antigen-antibody reactions
Diabetes
Drug delivery systems
Drugs
Gene therapy
Health aspects
Insulin
Pharmaceutical industry
Vehicles
United States
Online AccessGet full text

Cover

More Information
Summary:Since its introduction, insulin therapy for diabetes has long been equated with pain, anxiety, lifestyle inconvenience and potential injection-site irritation and lipodystrophy. Efforts to develop noninvasive methods for insulin delivery have relied on molecular modifications, absorption enhancers and encapsulation techniques to resist degradation, promote drug penetration and achieve therapeutic plasma insulin levels. Product development attempts have targeted virtually every mucosal membrane in the body for potential drug delivery. Each administration route has unique physiologic constraints. Potential alternative insulin therapies are discussed with their respective technical challenges. An overview of new drug-delivery platforms currently in development is also provided.
ISSN:1758-1907
1758-1915
DOI:10.2217/dmt.12.48